Today news
About the same in other media
Nestle Sells Peanut-Allergy Treatment Business to Stallergenes Greer
Reading now: 986
Nestle said it has sold its Palforzia peanut-allergy treatment business to biopharmaceutical company Stallergenes Greer. The Swiss consumer-goods company said Monday that it will receive milestone payments and royalties from Stallergenes Greer.
The deal was closed upon signing, Nestle said. The sale allows Nestle’s health-science operations to focus on its core strengths and key growth drivers, the unit’s Chief Executive Greg Behar said.
Nestle last year said that it would conduct a strategic review of Palforzia after a slower-than-expected adoption by patients and healthcare professionals. Write to Adria Calatayud at adria.calatayud@dowjones.com
. Read more on livemint.comAbout this in other media
Castlefield sells ACD unit to Thesis Unit Trust Management investmentweek.co.uk /1 year ago
BTS V is now the best-selling Korean soloist of all time! Debut album ‘Layover’ sells 2 mn copies on Hanteo economictimes.indiatimes.com /1 year ago
Bain sells a 2.82% stake in L&T Fin livemint.com /1 year ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
